Mesoporous silica nanoparticles in biomedical applications
Top Cited Papers
- 3 January 2012
- journal article
- review article
- Published by Royal Society of Chemistry (RSC) in Chemical Society Reviews
- Vol. 41 (7), 2590-2605
- https://doi.org/10.1039/c1cs15246g
Abstract
This tutorial review provides an outlook on nanomaterials that are currently being used for theranostic purposes, with a special focus on mesoporous silica nanoparticle (MSNP) based materials. MSNPs with large surface area and pore volume can serve as efficient carriers for various therapeutic agents. The functionalization of MSNPs with molecular, supramolecular or polymer moieties, provides the material with great versatility while performing drug delivery tasks, which makes the delivery process highly controllable. This emerging area at the interface of chemistry and the life sciences offers a broad palette of opportunities for researchers with interests ranging from sol–gel science, the fabrication of nanomaterials, supramolecular chemistry, controllable drug delivery and targeted theranostics in biology and medicine.Keywords
This publication has 70 references indexed in Scilit:
- Magnetic resonance imaging of high intensity focused ultrasound mediated drug delivery from temperature-sensitive liposomes: An in vivo proof-of-concept studyJournal of Controlled Release, 2011
- Multi-functional liposomes having temperature-triggered release and magnetic resonance imaging for tumor-specific chemotherapyBiomaterials, 2011
- Pegylated liposomal doxorubicin and gemcitabine in patients with advanced hepatocellular carcinomaCancer, 2010
- Radioactive liposomesWIREs Nanomedicine and Nanobiotechnology, 2008
- Paul Ehrlich's magic bullet concept: 100 years of progressNature Reviews Cancer, 2008
- Nanocarriers as an emerging platform for cancer therapyNature Nanotechnology, 2007
- Nanoparticles in Medicine: Therapeutic Applications and DevelopmentsClinical Pharmacology & Therapeutics, 2007
- Mechanism of tumor-targeted delivery of macromolecular drugs, including the EPR effect in solid tumor and clinical overview of the prototype polymeric drug SMANCSJournal of Controlled Release, 2001
- Recognition by macrophages and liver cells of opsonized phospholipid vesicles and phospholipid headgroups.Pharmaceutical Research, 2001
- Selective delivery of doxorubicin to patients with breast carcinoma metastases by stealth liposomesCancer, 1999